Emalex Biosciences

Emalex Biosciences is developing new treatments for central nervous system disorders including Tourette syndrome.

When continued on ecopipam, 41.9% of children had their symptoms relapse, significantly lower than the 68.1% rate seen in children given placebo.

Darren Incorvaia Feb 25, 2025 1:18pm

Apr 11, 2023 9:19am

Nov 3, 2022 7:00am